Trial Outcomes & Findings for 3T MR Angiography of the Hepatic Vasculature (NCT NCT02299934)
NCT ID: NCT02299934
Last Updated: 2019-05-07
Results Overview
TERMINATED
NA
13 participants
Day 1
2019-05-07
Participant Flow
Participant milestones
| Measure |
Subjects Who Fulfill the Criteria for Living Liver Donation
Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.
|
|---|---|
|
Overall Study
STARTED
|
13
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
13
|
Reasons for withdrawal
| Measure |
Subjects Who Fulfill the Criteria for Living Liver Donation
Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.
|
|---|---|
|
Overall Study
Termination of study
|
13
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Subjects Who Fulfill the Criteria for Living Liver Donation
n=13 Participants
Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=13 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
13 Participants
n=13 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=13 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=13 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=13 Participants
|
|
Region of Enrollment
United States
|
13 participants
n=13 Participants
|
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Day 1Population: Study was terminated prior to collecting any outcome measure data.
Outcome measures
Outcome data not reported
Adverse Events
Subjects Who Fulfill the Criteria for Living Liver Donation
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place